Foster & Motley Inc. Acquires New Shares in Tenet Healthcare Corporation $THC

Foster & Motley Inc. purchased a new stake in Tenet Healthcare Corporation (NYSE:THC) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 8,704 shares of the company’s stock, valued at approximately $1,628,000.

Other large investors have also added to or reduced their stakes in the company. Triumph Capital Management purchased a new position in Tenet Healthcare during the third quarter worth about $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the 4th quarter valued at about $26,000. Elyxium Wealth LLC bought a new position in shares of Tenet Healthcare in the fourth quarter worth approximately $29,000. Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare in the second quarter valued at approximately $35,000. Finally, Trust Co. of Vermont bought a new stake in Tenet Healthcare during the second quarter valued at approximately $37,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Down 0.4%

Shares of Tenet Healthcare stock opened at $269.11 on Thursday. The company’s fifty day simple moving average is $216.42 and its two-hundred day simple moving average is $205.69. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $277.76. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The company has a market cap of $21.67 billion, a P/E ratio of 10.38, a PEG ratio of 1.03 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. During the same period last year, the business posted $4.02 earnings per share. Tenet Healthcare’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Research analysts anticipate that Tenet Healthcare Corporation will post 20.97 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Guggenheim raised their price target on Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a research report on Tuesday, July 28th. Truist Financial increased their price objective on Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research report on Tuesday, July 28th. Wall Street Zen downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Raymond James Financial reiterated an “outperform” rating and set a $285.00 price target on shares of Tenet Healthcare in a research report on Friday, August 14th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a report on Monday, July 27th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and an average target price of $273.00.

Insider Buying and Selling

In other news, Director Tammy Romo sold 2,500 shares of the firm’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $260.83, for a total transaction of $652,075.00. Following the sale, the director owned 28,284 shares of the company’s stock, valued at $7,377,315.72. This trade represents a 8.12% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Christopher S. Lynch sold 3,837 shares of the firm’s stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $243.44, for a total transaction of $934,079.28. Following the completion of the sale, the director owned 9,568 shares in the company, valued at $2,329,233.92. This represents a 28.62% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 41,375 shares of company stock worth $9,793,347 in the last three months. 0.97% of the stock is currently owned by company insiders.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.